Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas
Adult
Male
0301 basic medicine
Adolescent
Receptors, Notch
Gene Expression Profiling
Gene Expression
Middle Aged
Gene Expression Regulation, Neoplastic
Pancreatic Neoplasms
Wnt Proteins
Neuroendocrine Tumors
Young Adult
03 medical and health sciences
Neural Crest
Case-Control Studies
Biomarkers, Tumor
Humans
Female
beta Catenin
Oligonucleotide Array Sequence Analysis
Signal Transduction
DOI:
10.1002/path.2524
Publication Date:
2009-01-20T12:09:36Z
AUTHORS (11)
ABSTRACT
AbstractSolid‐pseudopapillary neoplasms (SPNs) are rare human pancreatic neoplasms usually associated with a good prognosis. In contrast to other pancreatic tumours, aberrant activation of the Wnt–β‐catenin pathway appears to be a constant feature in SPN. Aside from activation of the Wnt–β‐catenin pathway, little is known about biological pathways deregulated in SPN. We carried out transcriptome profiling of SPN to gain insights into the pathogenesis of these tumours. As expected, the over‐expression of AXIN2, TBX3, SP5 and NOTUM demonstrated activation of the β‐catenin pathway. Members of the Notch pathway (HEY1, HEY2, NOTCH2) were also up‐regulated, relative to their expression in ductal adenocarcinomas (DAC) or pancreatic endocrine tumours (PET). Other genes, such as EDN3, HAND2, netrin‐G2 and the receptor netrin‐G1 ligand, involved in neural crest differentiation, were also identified as altered. Increased levels of SOX10 and TuJ‐1 proteins were also indicative of neural‐like differentiation. In conclusion, SPN display a complex expression profile, distinct from that observed in PET and DAC and involving both the β‐catenin and Notch pathways, together with expression of neural differentiation markers. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (54)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....